These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7610109)

  • 1. [Calcium antagonists of the dihydropyridine type: pharmaceutical chemistry and molecular pharmacology].
    Mannhold R
    Pharm Unserer Zeit; 1995 Jun; 24(3):137-53. PubMed ID: 7610109
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interaction of 1,4-dihydropyridines with ion channels].
    Veizerová L; Svetlík J; Kettmann V
    Ceska Slov Farm; 2008 Apr; 57(2):58-62. PubMed ID: 18578414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genesis of dihydropyrimidinone(psi) calcium channel blockers: recent progress in structure-activity relationships and other effects.
    Singh K; Arora D; Singh K; Singh S
    Mini Rev Med Chem; 2009 Jan; 9(1):95-106. PubMed ID: 19149663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR study of 1,4-dihydropyridine calcium channel antagonists based on gene expression programming.
    Si HZ; Wang T; Zhang KJ; Hu ZD; Fan BT
    Bioorg Med Chem; 2006 Jul; 14(14):4834-41. PubMed ID: 16580211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR, diagnostic statistics and molecular modelling of 1,4-dihydropyridine calcium antagonists: a difficult road ahead.
    Mager PP; Coburn RA; Solo AJ; Triggle DJ; Rothe H
    Drug Des Discov; 1992 Jul; 8(4):273-89. PubMed ID: 1445993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure-activity relationship study on 2-, 5-, and 6-position of the water soluble 1,4-dihydropyridine derivatives blocking N-type calcium channels.
    Yamamoto T; Niwa S; Ohno S; Tokumasu M; Masuzawa Y; Nakanishi C; Nakajo A; Onishi T; Koganei H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Shoji M
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4813-6. PubMed ID: 18684623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 1,4-dihydropyridine nucleus: a pharmacophoric template part 1. Actions at ion channels.
    Triggle DJ
    Mini Rev Med Chem; 2003 May; 3(3):215-23. PubMed ID: 12570837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis on the physicochemical properties of dihydropyridine calcium channel blockers in grapefruit juice interactions.
    Uesawa Y; Takeuchi T; Mohri K
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1705-17. PubMed ID: 22039822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 1): action in ion channels and GPCRs.
    Ioan P; Carosati E; Micucci M; Cruciani G; Broccatelli F; Zhorov BS; Chiarini A; Budriesi R
    Curr Med Chem; 2011; 18(32):4901-22. PubMed ID: 22050742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-activity relationship study of recently synthesized 1,4-dihydropyridine calcium channel antagonists. Application of the Hansch analysis method.
    Hemmateenejad B; Miri R; Akhond M; Shamsipur M
    Arch Pharm (Weinheim); 2002 Dec; 335(10):472-80. PubMed ID: 12506395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between neural networks (NN) and principal component analysis (PCA): structure activity relationships of 1,4-dihydropyridine calcium channel antagonists (nifedipine analogues).
    Takahata Y; Costa MC; Gaudio AC
    J Chem Inf Comput Sci; 2003; 43(2):540-4. PubMed ID: 12653519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, spectroscopic, DFT, and molecular docking studies on 1,4-dihydropyridine derivative compounds: a combined experimental and theoretical study.
    Karthick R; Velraj G; Pachamuthu MP; Karthikeyan S
    J Mol Model; 2021 Dec; 28(1):5. PubMed ID: 34889990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety.
    Budriesi R; Bisi A; Ioan P; Rampa A; Gobbi S; Belluti F; Piazzi L; Valenti P; Chiarini A
    Bioorg Med Chem; 2005 May; 13(10):3423-30. PubMed ID: 15848754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels.
    Yamamoto T; Niwa S; Ohno S; Onishi T; Matsueda H; Koganei H; Uneyama H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Shoji M
    Bioorg Med Chem Lett; 2006 Feb; 16(4):798-802. PubMed ID: 16309909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of thyroid hormone uptake by calcium antagonists of the dihydropyridine class.
    Scholz GH; Vieweg S; Uhlig M; Thormann M; Klossek P; Goldmann S; Hofmann HJ
    J Med Chem; 1997 May; 40(10):1530-8. PubMed ID: 9154974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active conformation of 1,4-dihydropyridine calcium entry blockers. Effect of size of 2-aryl substituent on rotameric equilibria and receptor binding.
    Rovnyak G; Andersen N; Gougoutas J; Hedberg A; Kimball SD; Malley M; Moreland S; Porubcan M; Pudzianowski A
    J Med Chem; 1991 Aug; 34(8):2521-4. PubMed ID: 1652021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Derivatives of 1,4-dihydropyridines as "priviledged structures" and their pharmacological potential].
    Żorniak M; Mitręga K; Krzemiński TF
    Kardiol Pol; 2011; 69 Suppl 3():100-3. PubMed ID: 22125212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The discovery of calcium antagonists].
    Goldmann S
    Pharm Unserer Zeit; 2005; 34(5):366-73. PubMed ID: 16180358
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.
    Katoh M; Nakajima M; Shimada N; Yamazaki H; Yokoi T
    Eur J Clin Pharmacol; 2000; 55(11-12):843-52. PubMed ID: 10805063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities.
    Liang JC; Yeh JL; Wang CS; Liou SF; Tsai CH; Chen IJ
    Bioorg Med Chem; 2002 Mar; 10(3):719-30. PubMed ID: 11814861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.